FDA Drug Application (021202) for GLUCOPHAGE XR by BRISTOL MYERS SQUIBB

Back to FDA Applications sponsored by BRISTOL MYERS SQUIBB

Application Number021202
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage500MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB1 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameGLUCOPHAGE XR
Active IngredientMETFORMIN HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient METFORMIN HYDROCHLORIDE32


Back to FDA Applications sponsored by BRISTOL MYERS SQUIBB